Title: The Effect of Nafamostat Mesilate Infusion after ERCP for Post-ERCP Pancreatitis
Version: 3 Date: 08 Apr 2022
Reviewer's report:
Dear authors, I am very glad to see that you have accepted revision suggestions. I stand by my
opinion that it is interesting  paper, especially because you have focused on high risk patients
group.
Title: The Effect of Nafamostat Mesilate Infusion after ERCP for Post-ERCP Pancreatitis
Version: 3 Date: 08 Apr 2022
Reviewer's report:
Dear authors, I am very glad to see that you have accepted revision suggestions. I stand by my
opinion that it is interesting  paper, especially because you have focused on high risk patients
group.
Please review this paper.
user
Title: The Effect of Nafamostat Mesilate Infusion after ERCP for Post-ERCP Pancreatitis
Version: 3 Date: 08 Apr 2022
Reviewer's report:
Dear authors, I am very glad to see that you have accepted revision suggestions. I stand by my
opinion that it is interesting  paper, especially because you have focused on high risk patients
group.
assistant